Comparison of Butorphanol and Tramadol Associated Patient-Controlled Analgesia (PCA) After Hysterectomy

NCT00510666 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 841

Last updated 2009-03-31

No results posted yet for this study

Summary

Intravenous patient-controlled analgesia (PCA) is a popular technique for postoperative pain management. Although several drugs are recognized as effective therapeutic options, optimal selection of drugs in hysterectomy patients underwent different anesthesia treatments remains unknown explicitly. The investigators hypothesized that butorphanol and tramadol can produce different analgesic effects with intravenous PCA after abdominal hysterectomy.

Conditions

  • Postoperative Pain
  • Hysterectomy

Interventions

DRUG

Saline

Saline infusion adjunct to morphine PCA pump

DRUG

Butorphanol tartrate

Butorphanol was delivered at a continuous infusion manner adjunct to morphine PCA pump

DRUG

Tramadol Hydrochloride

100mg tramadol was used preemptively to morphine PCA pump

DRUG

Saline

Preemptive saline as a control group to tramadol one

Sponsors & Collaborators

  • HRSA/Maternal and Child Health Bureau

    collaborator FED
  • Nanjing Medical University

    lead OTHER

Principal Investigators

  • XiaoFeng Shen, MD · Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00510666 on ClinicalTrials.gov